A detailed history of Aviva PLC transactions in Pfizer Inc stock. As of the latest transaction made, Aviva PLC holds 3,365,818 shares of PFE stock, worth $97.9 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
3,365,818
Previous 2,711,468 24.13%
Holding current value
$97.9 Million
Previous $75.2 Million 25.16%
% of portfolio
0.27%
Previous 0.27%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$25.26 - $29.6 $16.5 Million - $19.4 Million
654,350 Added 24.13%
3,365,818 $94.2 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $6.08 Million - $6.98 Million
-234,918 Reduced 7.97%
2,711,468 $75.2 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $4.2 Million - $5.45 Million
160,724 Added 5.77%
2,946,386 $84.8 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $3.54 Million - $4.14 Million
-110,279 Reduced 3.81%
2,785,662 $92.4 Million
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $20.6 Million - $23.8 Million
569,435 Added 24.48%
2,895,941 $106 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $2.43 Million - $3.16 Million
61,573 Added 2.72%
2,326,506 $94.9 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $12.5 Million - $16.3 Million
299,014 Added 15.21%
2,264,933 $116 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $3.06 Million - $3.74 Million
69,981 Added 3.69%
1,965,919 $86 Million
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $22.3 Million - $26.4 Million
478,364 Added 33.75%
1,895,938 $99.4 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $25 Million - $30.9 Million
545,719 Added 62.59%
1,417,574 $73.4 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $6.97 Million - $10.3 Million
-168,591 Reduced 16.2%
871,855 $51.5 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $32.3 Million - $41.5 Million
-822,465 Reduced 44.15%
1,040,446 $44.8 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $4.55 Million - $5.16 Million
-126,794 Reduced 6.37%
1,862,911 $73 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $136,974 - $154,479
-4,090 Reduced 0.21%
1,989,705 $72.1 Million
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $1.55 Million - $1.97 Million
46,249 Added 2.37%
1,993,795 $73.4 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $2.4 Million - $2.82 Million
-75,602 Reduced 3.74%
1,947,546 $71.5 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $2.5 Million - $3.04 Million
-83,118 Reduced 3.95%
2,023,148 $66.2 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $973,458 - $1.39 Million
36,014 Added 1.74%
2,106,266 $68.7 Million
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $1.4 Million - $1.59 Million
-42,539 Reduced 2.01%
2,070,252 $81.1 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $39.5 Million - $51.2 Million
-1,214,996 Reduced 36.51%
2,112,791 $75.9 Million
Q2 2019

Jul 30, 2019

SELL
$36.98 - $41.52 $12.8 Million - $14.4 Million
-346,197 Reduced 9.42%
3,327,787 $144 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $1.45 Million - $1.59 Million
-38,583 Reduced 1.04%
3,673,984 $156 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $24.9 Million - $28.4 Million
-648,143 Reduced 14.86%
3,712,567 $162 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $9.31 Million - $11.3 Million
-270,141 Reduced 5.83%
4,360,710 $192 Million
Q2 2018

Aug 01, 2018

SELL
$32.98 - $35.16 $6.43 Million - $6.85 Million
-194,833 Reduced 4.04%
4,630,851 $168 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $11.5 Million - $13.3 Million
-359,048 Reduced 6.93%
4,825,684 $171 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $16.3 Million - $17.3 Million
-491,195 Reduced 8.65%
5,184,732 $188 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.85 Million - $2.04 Million
59,693 Added 1.06%
5,675,927 $203 Million
Q2 2017

Aug 07, 2017

BUY
N/A
5,616,234
5,616,234 $189 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.